--- title: "Offshore Capital Reassesses Hong Kong Periphery as Property Liquidations Contrast with Green Resilience" type: "News" locale: "en" url: "https://longbridge.com/en/news/295514137.md" description: "As global liquidity shifts, Hong Kong's peripheral equities face stark bifurcation. Renewable transitions secure premium valuations amidst decarbonization mandates, while heavily indebted property and infrastructure conglomerates succumb to terminal liquidation pressures." datetime: "2026-08-11T09:42:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295514137.md) - [en](https://longbridge.com/en/news/295514137.md) - [zh-HK](https://longbridge.com/zh-HK/news/295514137.md) generator: "portal-rs" --- # Offshore Capital Reassesses Hong Kong Periphery as Property Liquidations Contrast with Green Resilience The shifting contours of global liquidity are forcing a stringent reassessment of Hong Kong's peripheral equities, separating resilient structural plays from debt-burdened conglomerates as offshore capital recalibrates its risk tolerance. Adapting to this demanding macro environment, Fubon Fund Management (9196.HK) exemplifies the strategic pivot within financial services toward retail wealth preservation solutions. Concurrently, specialized biotech remains a rare bright spot for structural inflows; Ocumension Therapeutics (6877.HK) continues to leverage domestic demographic trends and a robust ophthalmic pipeline to sustain commercialization momentum, insulating itself from broader cyclical headwinds. Strategic alignment with global decarbonization mandates has become a critical differentiator for capital retention. China Resources Power (0889.HK) is cementing its leadership in this transition, aggressively expanding its renewable portfolio to nearly half of its total capacity and securing decade-long green energy pacts with multinational partners to anchor its institutional valuation. Conversely, export-oriented players such as Tongfang Technovator (3613.HK) and Come Sure Group (1666.HK) are contending with fractured global supply chains. These consumer manufacturing entities are increasingly relying on complex corporate spin-offs and brand optimizations to defend their margins against deteriorating cross-border consumer sentiment. However, the gravest systemic risks remain concentrated in the remnants of the property and infrastructure boom, where offshore tolerance for leverage has completely evaporated. Construction-linked entities including Jianzhi Education (8049.HK) and Activation Group (2459.HK) have endured severe revenue contractions amid stalling domestic fixed-asset investment. The fallout is most profound among sprawling conglomerates; Imperium Technology Group (1901.HK) and Evergrande Auto (2279.HK) demonstrate the perilous and unsustainable nature of combining ailing property operations with cash-burning electric vehicle ambitions. The terminal phase of this prolonged credit cycle was laid bare by the court-ordered liquidation of New New Urbanization (1799.HK) following insurmountable offshore liabilities, underscoring a permanent repricing of corporate governance and debt risks across the region. ### Related Stocks - [03613.HK](https://longbridge.com/en/quote/03613.HK.md) - [08049.HK](https://longbridge.com/en/quote/08049.HK.md) - [02459.HK](https://longbridge.com/en/quote/02459.HK.md) - [01901.HK](https://longbridge.com/en/quote/01901.HK.md) - [01666.HK](https://longbridge.com/en/quote/01666.HK.md) - [06877.HK](https://longbridge.com/en/quote/06877.HK.md) - [02279.HK](https://longbridge.com/en/quote/02279.HK.md) - [01799.HK](https://longbridge.com/en/quote/01799.HK.md) ## Related News & Research - [Tong Ren Tang Tech FY26 H1 profit attributable to owners drops 26.43% to RMB 249.14 million; revenue falls 19.1% to RMB 3.02 billion](https://longbridge.com/en/news/297314873.md) - [Tong Ren Tang Technologies signs new e-commerce services deal with Tong Ren Tang Shuzi Technology through 2028](https://longbridge.com/en/news/297315704.md) - [Beijing Tong Ren Tang Chinese Medicine wins Hong Kong registration certificate for Sanzi Yangqin granules](https://longbridge.com/en/news/297315796.md) - [Yonghe Medical FY26 H1 net profit more than doubles to RMB 75.5 million; revenue rises 13.8% to RMB 980.6 million](https://longbridge.com/en/news/296470408.md) - [Yonghe Medical Moves to Modernize Governance With New Articles of Association](https://longbridge.com/en/news/281514752.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**